ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Promoter Aceso Research Labs LLP acquired 25,417 equity shares of Astal Laboratories Ltd via market purchase, increasing their stake from 4.53% to 4.59%.
Astal Laboratories' promoter ACESO Research Labs LLP bought equity shares on BSE under a SEBI PIT disclosure. The open-market purchase signals promoter confidence.
Astal Laboratories has submitted its Annual Report for the financial year 2025-26 and the notice for its 33rd Annual General Meeting scheduled for September 29, 2026.
Astal Laboratories will hold its 33rd Annual General Meeting on September 29, 2026. The company also announced book closure and e-voting dates.
Astal Laboratories Limited appointed Avnesh Jain & Co. as Cost Auditors for the financial year 2026-27.
Astal Laboratories approved its Board Report, appointed Cost Auditors, and scheduled its 33rd Annual General Meeting for September 29, 2026, alongside related administrative matters.
Astal Laboratories Limited has scheduled a board meeting on September 04, 2026, to approve the notice of the 33rd AGM and the Board Report.
Astal Laboratories submitted a statement confirming no deviation in the utilization of previously raised funds for the quarter ended June 30, 2026, as per SEBI regulations.
Astal Laboratories Ltd reported revenue from operations of ₹100.9 Cr and net profit of ₹9.4 Cr for Q1 FY27.
Astal Laboratories Ltd will hold a board meeting on August 14, 2026, to consider and approve the unaudited standalone and consolidated financial results.